Source: Annual Congress 2007 - Novel genetic markers in pathology
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
G. E. Carpagnano, A. Spanevello, C. Curci, M. G. Cagnazzo, M. P. Foschino Barbaro (Foggia, Italy). 3p microsatellite evaluation in NSCLC exhaled breath condensate: validation study. Eur Respir J 2007; 30: Suppl. 51, 3214

Member's Comments

No comment yet.

Related content which might interest you: Potentiality of detectionof microsatellite alterations in exhaled breath condensate of smokers as a tool for tumor susceptibility Source: Eur Respir J 2005; 26: Suppl. 49, 327s Year: 2005 Microsatellite alterations of 6p and 14p in the exhaled breath condensate of asthmatic subjects Source: Annual Congress 2007 - Novel genetic markers in pathology Year: 2007 Protein markers in the exhaled breath condensate of lung carcinoma patients Source: Annual Congress 2012 - Exhaled biomarkers in airway diseases Year: 2012 Early detection of lung cancer through analysis of VOC biomarkers in exhaled breath: The LuCID study. Source: International Congress 2017 – Lung cancer: clinical research on exhaled breath, clinical trials in advanced NSCLC and real-life appraisals of immunotherapies Year: 2017 Exhaled biomarkers in lung cancer Source: Eur Respir J 2009; 34: 261-275 Year: 2009 The validation of assays used to measure biomarkers in exhaled breath condensate Source: Eur Respir J 2008; 32: 1408-1409 Year: 2008 Lung disease diagnostic method based on proteomic analysis of exhaled breath condensate Source: International Congress 2019 – Basic research of airway diseases Year: 2019 Standardization of collection of exhaled breath condensate (EBC) for disease markers in use of different condensers Source: Eur Respir J 2003; 22: Suppl. 45, 448s Year: 2003 Reproducibility of exhaled breath condensate markers Source: Eur Respir J 2008; 32: Year: 2008 Attempt of detection of CYFRA 21-1 in exhaled breath condensate by patients with NSCLC Source: Eur Respir J 2006; 28: Suppl. 50, 85s Year: 2006 Metabolomic/proteomic analysis of biomarkers in exhaled breath condensates Source: Annual Congress 2008 - PG8 - Cellular and molecular technologies of today - treatments of tomorrow Year: 2008 Separate lung exhaled breath condensate collection confirms intrapulmonary origin of exhaled breath condensate acidification Source: Eur Respir J 2007; 30: Suppl. 51, 364s Year: 2007 HPV in exhaled breath condensate of lung cancer patients Source: Annual Congress 2011 - Role of the biomarkers in airway diseases Year: 2011 Detection and variability of cytokine-levels in exhaled breath condensate (EBC) of patients with stable COPD Source: Eur Respir J 2003; 22: Suppl. 45, 438s Year: 2003 Exhaled breath condensate sample collection: standards and open issues Source: Eur Respir Monogr 2010; 49: 152-161 Year: 2010 Detection of p53 mutation in exhaled breath condensate from patients with nonsmall cell lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 14s Year: 2002 Exhaled breath condensate is not suitable to detect EGFR somatic mutations Source: Eur Respir J 2008; 32: 1123-1124 Year: 2008 Exhaled breath condensate biomarkers in COPD Source: Eur Respir J 2008; 32: 472-486 Year: 2008 Diagnosis of lung diseases based on proteomic analysis of exhaled breath condensate Source: International Congress 2017 – Clinical problems in lung diseases Year: 2017 Inflammatory markers in exhaled breath condensate of two COPD phenotypes Source: Eur Respir J 2005; 26: Suppl. 49, 260s Year: 2005